Log in
APRINOIA Therapeutics
Contact
Links
Previous companies
View in org chart
Mark S. Shearman
CEO
Lili Zhang
SVP, Head of Preclinical Development
Masaomi Miyamoto
EVP of R&D & Operations
Tzu-Chen Yen
General Manager
Bradford A. Navia
Chief Medical Officer
+ 4 more
Yunhong Huang
Principal Scientist
February, 2022 - present
